close

Enter

Log in using OpenID

Compounding pharmacies market Estimated to Exhibit 7.5% CAGR in terms of value through 2025

embed
The global compounding pharmacies market is forecasted to be worth US$ 13,366.5 Mn by 2025 end and is expected to increase at a CAGR of 7.5% throughout forecast period.
According to the latest market report published by Persistence Market Research titled
‘Compounding Pharmacies Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’
the global compounding pharmacies market is expected to expand at a CAGR of 7.5% during the
forecast period 2017-2025. The revision in the market size and forecasts have been carried out
taking into account the impact of various macroeconomic indicators and other industry-based
demand-driving factors, as well as the recent developments of key market participants. The global
compounding pharmacies market is projected to expand at a healthy CAGR of 7.5% in terms of
value during the forecast period, revised from the previous CAGR of 4.4%, due to factors such as
increasing medicinal droughts of prescription medicine across the globe, regarding which
Persistence Market Research offers useful insights in detail in this report.
The primary factors driving revenue growth of the global compounding pharmacies market are
increasing medicinal droughts of prescription medicine, growing demand for HRT drugs, and
increase in demand for topical products – these factors will upsurge the growth of the compounding
pharmacies market in the coming years. Increasing restricted formulations and unsafe compounding
practices are some of the factors that will restrain the growth of the compounding pharmacies
market over the forecast period.
Segmental Forecast of the Global Compounding Pharmacies Market
The market is segmented based on product type, application type, therapeutic area and region. On
the basis of product type the market has been segmented as oral medication, topical medication,
mouthwashes and suppositories. By product type, the oral medication segment is expected to
remain the largest segment, registering a CAGR of 9.5% in terms of value over the forecast period.
The oral medication product type segment is expected to reach a market value of US$ 6,357.7 Mn
by 2025 end.
On the basis of application type, the compounding pharmacies market has been segmented as
medication for adults, medication for veterinary, medication for children and medication for
geriatric. The medication for adults segment is expected to remain the largest segment, registering a
CAGR of 9.0% in terms of value over the forecast period. The medication for adults application
type segment is expected to reach a market value of US$ 7,588.7 Mn by 2025 end.
Get Full Report now – https://www.persistencemarketresearch.com/checkout/19396
On the basis of therapeutic area, the compounding pharmacies market has been segmented as pain
management and hormone replacement therapy. By therapeutic area, hormone replacement therapy
is expected to remain the largest segment, registering a CAGR of 9.9% in terms of value over the
forecast period. The hormone replacement therapy segment is expected to reach a market value of
US$ 9,380.7 Mn by 2025 end.
On the basis of region, the market has been segmented into North America, Latin America, Europe,
Asia Pacific, and Middle East and Africa. North America dominated the global compounding
pharmacies market with maximum value share of the overall market in 2016. The North America
compounding pharmacies market is expected to register the highest CAGR of 7.6% over the
forecast period to reach a market value of US$ 8,953.3 Mn by 2025 end.
Leading Companies in the Global Compounding Pharmacies Market
Some key players in the global compounding pharmacies market across the value chain are B.
Braun Melsungen AG Company, Fagron, PharMEDium Services, LLC, Institutional Pharmacy
Solutions, Cantrell Drug Company, Lorraine’s Pharmacy, and Fresenius Kabi AG. The report
identifies company specific strategies related to product development, market consolidation
initiatives and analysis of companies’ specific strengths, weaknesses, opportunities and threats.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses achieve
optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying
real-time data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: [email protected]
Web:https://www.persistencemarketresearch.com/
Author
mahendralunkad
mahendralunkad37   documents Email
Document
Category
Health and Medicine
Views
69
File Size
20 KB
Tags
pharmacies, Compounding Pharmacies Market
1/--pages
Report inappropriate content